Bharat Biotech

Indian biotechnology company and vaccine manufacturer

Bharat Biotech ▸ Facts ▸ Comments ▸ News ▸ Videos

Bharat Biotech International Limited is an Indian biotechnology company headquartered in Hyderabad, India engaged in the drug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products.

0 shares	Share Tweet Save Post Send



Nurses share experience after administering COVID vaccine to PM Modi Prime Minister Narendra Modi took his second shot of COVID-19 vaccine at AIIMS, Delhi on April 08. He received the first dose of Bharat Biotech's COVAXIN on March 01. "I have given the second dose of.. Credit: ANI Duration: 01:16Published 2 days ago

PM Modi gets Covid-19 vaccine second dose, says 'if eligible, get your shot' \| Oneindia News Prime Minister Narendra Modi on Thursday took the second dose of the Covid-19 vaccine at All India Institute of Medical Sciences (AIIMS) in New Delhi. He had received the first dose of Bharat Biotech's.. Credit: Oneindia Duration: 01:11Published 2 days ago

Watch: PM Modi receives second dose of Covid vaccine; nurses share experience Prime Minister Narendra Modi took his second dose of Covid-19 vaccine at AIIMS on April 8. Nisha Sharma administered the second dose of covid-19 vaccine to the prime minister. PM Modi asked those.. Credit: HT Digital Content Duration: 02:24Published 2 days ago

PM Modi takes 2nd jab of COVID-19 vaccine at AIIMS Prime Minister Narendra Modi took his second dose of COVID-19 vaccine at AIIMS on April 08. He received the first dose of Bharat Biotech's COVAXIN on March 01. He urged citizens who are eligible for.. Credit: ANI Duration: 01:26Published 2 days ago

Covid: Delhi Dy CM gets first vaccine jab as capital faces infection surge Delhi Deputy Chief Minister Manish Sisodia and his wife Seema received their first vaccine dose as the national capital faces a fresh infection surge. They were given Bharat Biotech's Covaxin at.. Credit: HT Digital Content Duration: 03:49Published 1 week ago

Watch: Harsh Vardhan takes 2nd dose of Covaxin, says 7 more vaccines in trials Union Health Minister Harsh Vardhan and his wife Nutan Goel took the second dose of Covid-19 vaccine. Harsh Vardhan and his wife got the vaccine at Delhi Heart and Lung Institute on Tuesday. Both.. Credit: HT Digital Content Duration: 05:01Published 2 weeks ago

‘India doing its best…’: Costa Rica, Paraguay request COVAXIN supply Ambassadors of Paraguay and Costa Rica expressed their keenness on getting supply of Covaxin, the indigenous Covid-19 vaccine developed by Bharat Biotech in collaboration with ICMR. They also hailed.. Credit: HT Digital Content Duration: 03:49Published 3 weeks ago

Watch: Ramdas Athawale, his wife take first shot of Covid-19 vaccine in Mumbai Union Minister Ramdas Athawale took the first shot of covid vaccine in Mumbai. Athawale was administered Covaxin, the Indian-researched and produced anti-Covid-19 vaccine. Covaxin is produced by Bharat.. Credit: HT Digital Content Duration: 01:44Published on March 12, 2021

Union Minister Ramdas Athawale takes first covid vaccine Union Minister Ramdas Athawale took the first shot of covid vaccine on Mar 12 in Mumbai. He was administered Covaxin, the Indian-researched and produced anti-COVID-19 vaccine, produced by Bharat.. Credit: ANI Duration: 01:22Published on March 12, 2021

Uddhav Thackeray: We Don’t Have To Learn Hindutva From You \| Oneindia News Arvind Kejriwal slams BJP saying the party has failed to govern the municipal corporations in Delhi. Karnataka Minister resigns on moral grounds after tape scandal. Maharashtra Chief Minister Uddhav.. Credit: Oneindia Duration: 02:43Published on March 3, 2021

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN.. Credit: ANI Duration: 01:42Published on March 3, 2021

Covid-19 vaccination drive 2.0: PM Modi takes Covaxin shot, what does it mean? \| Oneindia News India's second phase of the vaccination drive began today, opening registerations for people above 60 years and those aged 45 in the second phase of the inoculation drive. In the second phase, Prime.. Credit: Oneindia Duration: 04:14Published on March 1, 2021

Covid vaccine: How to register, where to go, what you need \| All key details Phase 2 of India's Covid-19 vaccination drive was launched in high-profile manner on March 1 with Prime Minister Narendra Modi becoming one of the first beneficiaries. The second phase of the programme.. Credit: HT Digital Content Duration: 04:31Published on March 1, 2021

Controversy of 'comparing vaccines' laid to rest: AIIMS Director on PM taking COVID shot After Prime Minister Narendra Modi was administered Bharat Biotech's COVAXIN, AIIMS Director Dr Randeep Guleria said that the controversy comparing one vaccine to other has also been laid to rest. He.. Credit: ANI Duration: 01:26Published on March 1, 2021

Ministers decided to avail paid COVID vaccination facility: RS Prasad Union Minister Ravi Shankar Prasad on March 01 said that Prime Minister Narendra Modi has replied to all the people questioning that when will he get vaccinated. He further requested Opposition to.. Credit: ANI Duration: 01:45Published on March 1, 2021

You Might Like

Even as Covid vaccine demand rises, firms may take some weeks to up production Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and Bharat Biotech ramp up capacity, some of.. IndiaTimes - Published 18 hours ago
PM Modi receives second dose of COVID-19 vaccine at AIIMS Earlier, on March 1, PM Modi had taken the first dose of Bharat Biotech's Covaxin at AIIMS Delhi DNA - Published 3 days ago
Covid-19: Government's expert panel allows clinical trials for third dose of Covaxin Bharat Biotech presented amendments to the subject expert committee of the Drugs Controller General of India (DCGI) in the approved Phase 2 clinical trial protocol for administration of booster dose.. IndiaTimes - Published 1 week ago

Why Brazil has denied permission to import Bharat Biotech's Covaxin IndiaTimes - Published 1 week ago
Bharat Biotech, Biovet, Sapigen Biologix sign collaborative research agreement with CSIR-IICT Bharat Biotech International, Biovet, and Sapigen Biologix will identify mutually interesting projects to pursue under the agreement. DNA - Published 2 weeks ago
Govt raises gap between Covishield shots to 4-8 weeks The health ministry on Monday revised the interval between two doses of the Covishield vaccine to 4-8 weeks, from the existing 4-6 weeks, after evidence showed higher efficacy following a longer gap.. IndiaTimes - Published 3 weeks ago

Increase gap between two doses of Covishield to 6-8 weeks, Centre tells states The Centre on Monday said that the gap between the first and second doses of the AstraZeneca-Oxford University's Covishield vaccine should be increased to 6-8 weeks from the current 28 days.The Centre.. IndiaTimes - Published 3 weeks ago
Covaxin out of clinical trial mode, granted restricted emergency use authorisation The Centre on Thursday said Bharat Biotech's indigenously developed Covaxin is out of the "clinical trial mode" and that it has now been granted the regular restricted emergency use authorisation just.. IndiaTimes - Published on March 11, 2021
Expert panel recommends dropping ‘clinical trial mode’ tag for Covaxin In a move likely to boost the use of Bharat Biotech’s anti-Covid vaccine Covaxin, the drug regulator's subject expert committee (SEC) on Wednesday recommended doing away with the “clinical trial.. IndiaTimes - Published on March 10, 2021
CDSCO expert panel recommends Covaxin be moved out of 'clinical trial mode' An expert panel of India's central drugs authority on Wednesday recommended granting emergency use authorisation to Bharat Biotech's indigenously developed Covaxin while removing the condition for the.. IndiaTimes - Published on March 10, 2021

Lancet publishes Covaxin phase 2 trials data prestigious medical journal The Lancet has now published Phase 2 clinical trial results of Bharat Biotech's Covaxin. "Due to the difference in dosing regimens between Phase 1 (two doses given 2 weeks.. IndiaTimes - Published on March 9, 2021
Mexico experts recommend approving Indian vaccine A technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the Covaxin vaccine made by the Indian pharmaceutical company Bharat Biotech. The report by the.. IndiaTimes - Published on March 6, 2021
Delhi high court asks Serum Institute, Bharat Biotech to disclose capacity to manufacture Covid-19 vaccines "We are not utilising it fully. We are either donating it to foreign countries or selling it to foreign countries and are not vaccinating our own people. So there has to be that sense of responsibility.. IndiaTimes - Published on March 4, 2021	Covaxin shows 81% efficacy, say ICMR and Bharat Biotech This interim efficacy trend puts Covaxin at par with other global front-runner vaccines, the desi vaccine’s co-developer, the Indian Council for Medical Research (ICMR), said in a statement. The.. IndiaTimes - Published on March 3, 2021
Covaxin demonstrates 81% efficacy, says Bharat Biotech on Phase 3 results Covaxin is one of two Covid vaccines that was granted emergency use approval in the country in early January. DNA - Published on March 3, 2021	Bharat Biotech announces Phase 3 results: All you need to know IndiaTimes - Published on March 3, 2021
Covid-19: Interim clinical efficacy of Covaxin is 81%, says Bharat Biotech IndiaTimes - Published on March 3, 2021	PM Modi takes the shot, gives vaccine process a booster dose The PM, who is 70, was administered Covaxin, the indigenous vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). This decision too seemed deliberate.. IndiaTimes - Published on March 1, 2021
Chinese hackers target Indian vaccine makers Serum Institute, Bharat Biotech: Security firm IndiaTimes - Published on March 1, 2021	Bharat Biotech hails PM Modi for taking Covid-19 vaccine, says it will give a huge boost to immunisation campaign IndiaTimes - Published on March 1, 2021
PM Modi sends out key message as he takes Covaxin shot Prime Minister Narendra Modi was administered the first dose of Covid-19 vaccine on Monday. Among the two vaccines available in India, PM Modi was administered the Bharat Biotech's Covaxin, developed.. IndiaTimes - Published on March 1, 2021	'Powerful example for all Indians': Bharat Biotech after PM Modi takes Covaxin shot Prime Minister Narendra Modi on Monday (March 1) was administered the first dose of COVID-19 vaccine, Covaxin at the AIIMS, Delhi. DNA - Published on March 1, 2021
'Pata hi nahi chala': PM Modi on taking the first shot of COVID-19 vaccine PM Modi was administered Covaxin, developed by biotechnology firm Bharat Biotech and the Indian Council of Medical Research. DNA - Published on March 1, 2021	Covid-19: Bharat Biotech to supply 20 million doses of Covaxin to Brazil IndiaTimes - Published on February 26, 2021
Brazil to buy 20 million Covid-19 vaccines from India's Bharat Biotech Brazil's health ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the Covid-19 vaccine made by India's Bharat Biotech, for delivery between March and May. The ministry.. IndiaTimes - Published on February 26, 2021	Chhattisgarh rejects Bharat Biotech vaccine approved without efficacy data IndiaTimes - Published on February 11, 2021
Covaxin trials for kids likely soon in Nagpur Bharat Biotech, makers of indigenous Covid-19 vaccine Covaxin, is expected to start vaccine trial for children by February-end or early March this year. As per international regulations, only vaccines.. IndiaTimes - Published on February 6, 2021	Covaxin: With focus on globalisation, Bharat Biotech files for emergency use approval in Philippines New Delhi has gifted India-made Covishield vaccine of Oxford-AstraZeneca made by Serum Institute of India to 10 countries. DNA - Published on January 31, 2021
Bharat Biotech in pact with GSK, PATH to manufacture world's only malaria vaccine IndiaTimes - Published on January 27, 2021	Covaxin effectively neutralises UK variants: Bharat Biotech India's first indigenous Covid-19 vaccine Covaxin effectively neutralises the deadly and infectious UK variants of SARS-CoV-2 virus, reducing the possibility of mutant virus escape, its developer.. IndiaTimes - Published on January 27, 2021
Pfizer wants India to order Covid-19 vaccine before pursuing approval Pfizer Inc will pursue its request for India to approve its Covid-19 vaccine if the government commits to buying shots, the US drugmaker told Reuters on Monday, even as global supplies tighten. Pfizer.. IndiaTimes - Published on January 25, 2021	Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study India's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the.. IndiaTimes - Published on January 22, 2021
Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against Covid-19 developed by Bharat Biotech,.. IndiaTimes - Published on January 19, 2021	Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said. Out of the 45 lakh doses, the city-based vaccine.. IndiaTimes - Published on January 19, 2021
COVID-19: Who shouldn't take Covaxin? Bharat Biotech releases factsheet as concerns grow Bharat Biotech issued the factsheet just two days after the launch of vaccination drive in the country. DNA - Published on January 19, 2021	COVID-19: Bharat Biotech to pay compensation for any side effect of Covaxin, details here Bharat Biotech, has received a government purchase order for the supply of 55 lakh doses of Covaxin. DNA - Published on January 16, 2021
Compensation if Covaxin causes serious adverse effect Beneficiaries who receive Covaxin, a Bharat Biotech product, will be paid a compensation if they suffer a serious adverse event that is proven to be causally related to the vaccine. Beneficiaries of.. IndiaTimes - Published on January 15, 2021	India plans 20 million doses of vaccine supply to neighbours India plans to offer 20 million doses of coronavirus vaccine to its neighbours as it draws up a policy to supply vials to countries across the globe, people with knowledge of the matter said. An Indian.. IndiaTimes - Published on January 15, 2021
Experts question govt vaccine purchase price, say it’s higher As the Covid-19 vaccine completes its journey from laboratory to hospital, its pricing is being questioned. Public health activists and industry experts to whom TOI spoke said the government’s.. IndiaTimes - Published on January 14, 2021	Vaccine drive accelerates, doses reach far corners of India While SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and.. IndiaTimes - Published on January 13, 2021
Bharat Biotech commences dispatch of Covaxin, ships to 11 cities Vaccine maker Bharat Biotech commenced dispatches of indigenous Covid-19 vaccine Covaxin on Wednesday morning with the first lot of the vaccine doses being flown out of Hyderabad by national carrier.. IndiaTimes - Published on January 13, 2021	After Covishield, first batch of Bharat Biotech's Covaxin arrives in Delhi Both Covishield and Covaxin, the two COVID-19 vaccines, have received Emergency Use Authorisation from the government. DNA - Published on January 13, 2021
Covid vaccine recipients may not be able to pick & choose Even as the government plans to roll out the Covid vaccination drive with Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin, recipients may not have an option to choose which one they.. IndiaTimes - Published on January 12, 2021	Bharat Biotech inks pact to supply Covaxin to Brazil Vaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous Covid-19 vaccine Covaxin in the Brazilian.. IndiaTimes - Published on January 12, 2021
54.72 lakh Covid-19 vaccine doses received till Tuesday afternoon: Centre The Centre said 54.72 lakh Covid-19 vaccine doses have been received at designated national and state-level stores till Tuesday afternoon, and all the shots -- 1.1 crore from the Serum Institute of.. IndiaTimes - Published on January 12, 2021	Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for Covid-19 in Feb-March Buoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI)for its Covid-19 vaccine Covaxin, Bharat Biotech has said Phase-1 clinical trials of its new.. IndiaTimes - Published on January 8, 2021
Covid-19: Bharat Biotech enrolls 25,800 volunteers for Covaxin phase-3 clinical trials IndiaTimes - Published on January 7, 2021	All-India vaccine rollout set for next week: Govt The government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian.. IndiaTimes - Published on January 5, 2021
Bharat Biotech, Serum Institute pledge for smooth rollout of Covid-19 vaccines Vaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of Covid-19 vaccines in the country and the world. IndiaTimes - Published on January 5, 2021	Why Covaxin may have an edge against new virus variants The chairman and managing director of Bharat Biotech, Dr Kishna Ella, said its Covid-19 vaccine, Covaxin, would be effective on mutant strains of the coronavirus, and therefore is justified to receive.. IndiaTimes - Published on January 5, 2021

Bharat Biotech

Indian biotechnology company and vaccine manufacturer

Bharat Biotech ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Even as Covid vaccine demand rises, firms may take some weeks to up production

PM Modi receives second dose of COVID-19 vaccine at AIIMS

Covid-19: Government's expert panel allows clinical trials for third dose of Covaxin

Why Brazil has denied permission to import Bharat Biotech's Covaxin

Bharat Biotech, Biovet, Sapigen Biologix sign collaborative research agreement with CSIR-IICT

Govt raises gap between Covishield shots to 4-8 weeks

Increase gap between two doses of Covishield to 6-8 weeks, Centre tells states

Covaxin out of clinical trial mode, granted restricted emergency use authorisation

Expert panel recommends dropping ‘clinical trial mode’ tag for Covaxin

CDSCO expert panel recommends Covaxin be moved out of 'clinical trial mode'

Lancet publishes Covaxin phase 2 trials data

Mexico experts recommend approving Indian vaccine

Delhi high court asks Serum Institute, Bharat Biotech to disclose capacity to manufacture Covid-19 vaccines

Covaxin shows 81% efficacy, say ICMR and Bharat Biotech

Covaxin demonstrates 81% efficacy, says Bharat Biotech on Phase 3 results

Bharat Biotech announces Phase 3 results: All you need to know

Covid-19: Interim clinical efficacy of Covaxin is 81%, says Bharat Biotech

PM Modi takes the shot, gives vaccine process a booster dose

Chinese hackers target Indian vaccine makers Serum Institute, Bharat Biotech: Security firm

Bharat Biotech hails PM Modi for taking Covid-19 vaccine, says it will give a huge boost to immunisation campaign

PM Modi sends out key message as he takes Covaxin shot

'Powerful example for all Indians': Bharat Biotech after PM Modi takes Covaxin shot

'Pata hi nahi chala': PM Modi on taking the first shot of COVID-19 vaccine

Covid-19: Bharat Biotech to supply 20 million doses of Covaxin to Brazil

Brazil to buy 20 million Covid-19 vaccines from India's Bharat Biotech

Chhattisgarh rejects Bharat Biotech vaccine approved without efficacy data

Covaxin trials for kids likely soon in Nagpur

Covaxin: With focus on globalisation, Bharat Biotech files for emergency use approval in Philippines

Bharat Biotech in pact with GSK, PATH to manufacture world's only malaria vaccine

Covaxin effectively neutralises UK variants: Bharat Biotech

Pfizer wants India to order Covid-19 vaccine before pursuing approval

Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin

COVID-19: Who shouldn't take Covaxin? Bharat Biotech releases factsheet as concerns grow

COVID-19: Bharat Biotech to pay compensation for any side effect of Covaxin, details here

Compensation if Covaxin causes serious adverse effect

India plans 20 million doses of vaccine supply to neighbours

Experts question govt vaccine purchase price, say it’s higher

Vaccine drive accelerates, doses reach far corners of India

Bharat Biotech commences dispatch of Covaxin, ships to 11 cities

After Covishield, first batch of Bharat Biotech's Covaxin arrives in Delhi

Covid vaccine recipients may not be able to pick & choose

Bharat Biotech inks pact to supply Covaxin to Brazil

54.72 lakh Covid-19 vaccine doses received till Tuesday afternoon: Centre

Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for Covid-19 in Feb-March

Covid-19: Bharat Biotech enrolls 25,800 volunteers for Covaxin phase-3 clinical trials

All-India vaccine rollout set for next week: Govt

Bharat Biotech, Serum Institute pledge for smooth rollout of Covid-19 vaccines

Why Covaxin may have an edge against new virus variants